Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-02-2018 | Letter to the Editor

On the ¹⁸F–fluoride PET imaging quantification to predict ²²³Ra-dichloride treatment response

Authors: Eric Laffon, Henri de Clermont, Roger Marthan, Fredéric Paycha

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2018

Excerpt

Dear Editor, …

Murray I, Chittenden SJ, Denis-Bacelar AM, Hindorf C, Parker CC, Chua S, et al. The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2017; https://doi.org/10.1007/s00259-017-3744-y.

Lin C, Bradshaw TJ, Perk TG, Harmon S, Eickhoff J, Jallow N, et al. Repeatability of quantitative 18F-NaF PET: a multicenter study. J Nucl Med. 2016;57:1872–9.CrossRefPubMed

Laffon E, Lamare F, de Clermont H, Burger IA, Marthan R. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak. Eur Radiol. 2014;24:1964–70.CrossRefPubMed

Caubet O, Meunier V, Marthan R, Laffon E. Early assessment of treatment response in Takayasu arteritis: an 18FDG PET procedure. Clin Nucl Med. 2016;41:743–5.CrossRefPubMed

Lodge MA. Repeatability of SUV in oncologic ¹⁸F-FDG PET. J Nucl Med. 2017;58:523–32.CrossRefPubMedPubMedCentral

Etchebehere EC, Araujo JC, Fox PS, Swanston NM, Macapinlac HA, Rohren EM. Prognostic factors in patients treated with 223Ra: the role of skeletal tumor burden on baseline 18F-fluoride PET/CT in predicting overall survival. J Nucl Med. 2015;56:1177–84.CrossRefPubMed

JCGM. Evaluation of measurement data - guide to the expression of uncertainty in measurement. 2008; www.bipm.org, Sept 2008.

Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney Y, et al. The kinetics and reproducibility of ¹⁸F-sodium fluoride for oncology using current PET camera technology. J Nucl Med. 2012;53:1175–84.CrossRefPubMedPubMedCentral

Title: On the 18F–fluoride PET imaging quantification to predict 223Ra-dichloride treatment response
Authors: Eric Laffon
Henri de Clermont
Roger Marthan
Fredéric Paycha
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-017-3868-0

At a glance: The STEP trials

Springer Medicine

On the ¹⁸F–fluoride PET imaging quantification to predict ²²³Ra-dichloride treatment response

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2018

Could 68Ga-somatostatin analogues be an important alternative to 18F-DOPA PET/CT in pediatrics?

18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation

68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans

Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer

68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials